HiberGene - Rapid Molecular Test Kit for Healthcare Associated Infections

Diagnosing C. difficile infection early allows patients to be discharged earlier, frees up bed space and reduces costs. Clostridium difficile (C. difficile), the major cause of hospital-acquired diarrhoea, is highly infectious and can spread rapidly in healthcare facilities if not identified and contained quickly. Up to 25% of antibiotic-associated diarrhoea is caused by C. difficile infection¹. Outbreaks are common, with significant fatality rates (=20%)² and huge cost implications. C. difficile infection needs to be efficiently diagnosed to reduce patient readmission rates which can cost healthcare systems over $17 bn annually³